GenRx Entecavir entecavir (as monohydrate) 0.5mg tablet blister pack

Active ingredient:

entecavir, Quantity: 0.5 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Entecavir

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; macrogol 8000; microcrystalline cellulose; hyprolose; copovidone; hypromellose; crospovidone; titanium dioxide

Administration route:

Oral

Units in package:

30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Product summary:

Visual Identification: White colored, triangular shaped film coated tablets, engraved 'APO' on one side and '0.5' over 'ENT' on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-03-10